Congenital cytomegalovirus (CMV) infection is the leading infectious cause of neurological impairment for which, currently, there are no approved antenatal treatment options.The aim of this article was to summarize the available evidence on the use of valacyclovir during pregnancy to prevent and treat congenital CMV infection and disease.
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questions / Zammarchi, Lorenzo; Lazzarotto, Tiziana; Andreoni, Massimo; Giaché, Susanna; Campolmi, Irene; Pasquini, Lucia; Di Tommaso, Mariarosaria; Simonazzi, Giuliana; Tomasoni, Lina; Castelli, Francesco; Galli, Luisa; Borchi, Beatrice; Clerici, Pierangelo; Bartoloni, Alessandro; Tavio, Marcello; Trotta, Michele. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - ELETTRONICO. - (2020), pp. 0-0. [10.1016/j.cmi.2020.09.015]
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questions
Zammarchi, Lorenzo;Giaché, Susanna;Campolmi, Irene;Pasquini, Lucia;Di Tommaso, Mariarosaria;Tomasoni, Lina;Castelli, Francesco;Galli, Luisa;Bartoloni, Alessandro;Trotta, Michele
2020
Abstract
Congenital cytomegalovirus (CMV) infection is the leading infectious cause of neurological impairment for which, currently, there are no approved antenatal treatment options.The aim of this article was to summarize the available evidence on the use of valacyclovir during pregnancy to prevent and treat congenital CMV infection and disease.
| File | Dimensione | Formato | |
|---|---|---|---|
|
CMV_settembre 2020.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
1.22 MB
Formato
Adobe PDF
|
1.22 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
